Nod Infusion
Sort by
2 items
-
Business - MarketWatch
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.9 hours ago -
Business - Financial Times
EU ministers nod to support for nuclear energy ahead of UN climate summit
Bloc officials overcome deep divisions on atomic power but finance goal commitment remains unresolved2 days ago - Climate